Cargando…
Generating Real-World Evidence on the Quality Use, Benefits and Safety of Medicines in Australia: History, Challenges and a Roadmap for the Future
Australia spends more than $20 billion annually on medicines, delivering significant health benefits for the population. However, inappropriate prescribing and medicine use also result in harm to individuals and populations, and waste of precious health resources. Medication data linked with other r...
Autores principales: | Pearson, Sallie-Anne, Pratt, Nicole, de Oliveira Costa, Juliana, Zoega, Helga, Laba, Tracey-Lea, Etherton-Beer, Christopher, Sanfilippo, Frank M., Morgan, Alice, Kalisch Ellett, Lisa, Bruno, Claudia, Kelty, Erin, IJzerman, Maarten, Preen, David B., Vajdic, Claire M., Henry, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707536/ https://www.ncbi.nlm.nih.gov/pubmed/34948955 http://dx.doi.org/10.3390/ijerph182413345 |
Ejemplares similares
-
The Medicines Intelligence Centre of Research Excellence: Co-creating real-world evidence to support the evidentiary needs of Australian medicines regulators and payers
por: Pratt, Nicole, et al.
Publicado: (2022) -
Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia
por: Schaffer, Andrea L., et al.
Publicado: (2022) -
Long-term use of proton-pump inhibitors: whole-of-population patterns
in Australia 2013–2016
por: Daniels, Benjamin, et al.
Publicado: (2020) -
Rapid and substantial increases in anticoagulant use and expenditure in Australia following the introduction of new types of oral anticoagulants
por: Morgan, Alice, et al.
Publicado: (2018) -
Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia
por: Bruno, Claudia, et al.
Publicado: (2020)